Explore Agency Resources
HHS | CDC | CMS | FDA | HRSA | IHS | NIH
HHS
Assessing the Costs and Benefits of Extending Coverage of Immunosuppressive Drugs Under Medicare
Given the costs to Medicare associated with patients who stop taking immunosuppressive drugs due to cost and revert to developing ESRD, requiring subsequent dialysis and/or kidney transplantation, the Assistant Secretary for Planning and Evaluation analyzed the financial implications of extending Medicare coverage of only immunosuppressive drugs for the lifetime of the patient.
Advancing American Kidney Health Report
These initiatives are designed to tackle the challenges people living with kidney disease face throughout the stages of kidney disease, while also improving the lives of patients, their caregivers, and family members.
KidneyX
KidneyX seeks to improve the lives of the 850 million people currently affected worldwide by accelerating the development of drugs, devices, biologics and other therapies across the spectrum of kidney care including: Prevention, Diagnostics and Treatment.
Opportunity for Advancing Dialysis Care in Disaster Settings
The initiatives are designed to tackle the challenges people living with kidney disease face throughout the stages of kidney disease, while also improving the lives of patients, their caregivers, and family members.
The Special Diabetes Program for Indians: Estimates of Medicare Savings
Report estimating savings from the reduction in diabetes-related ESRD that has occurred since implementation of the Special Diabetes Program for Indians.
CDC
Chronic Kidney Disease Initiative
CDC’s CKD Initiative provides public health strategies for promoting kidney health. These strategies seek to prevent and manage risk factors for CKD, raise awareness of CKD and its complications, promote early diagnosis and treatment of CKD, and improve outcomes for people living with CKD.
Chronic Kidney Disease in the United States
A collaborative effort of CDC, other federal agencies, universities, and nonprofit organizations, Chronic Kidney Disease in the United States provides information to the public, health officials, health-related organizations, and researchers on CKD prevalence, health consequences, risk factors, and prevention and treatment strategies.
Chronic Kidney Disease Surveillance System
CDC’s CKD Surveillance System is the only interactive and most comprehensive collection of CKD-related data in the United States, helpful for monitoring progress toward achieving national Healthy People objectives.
CMS
Comprehensive ESRD Care Model
The Comprehensive ESRD Care (CEC) Model is designed to identify, test, and evaluate new ways to improve care for Medicare beneficiaries with End-Stage Renal Disease (ESRD). Through the CEC Model, CMS will partner with health care providers and suppliers to test the effectiveness of a new payment and service delivery model in providing beneficiaries with person-centered, high-quality care.
End Stage Renal Disease (ESRD) Quality Measures
The University of Michigan Kidney and Epidemiology Cost Center (UM-KECC), develops, maintains, and updates the End Stage Renal Disease (ESRD) Quality Measures for the Centers for Medicare and Medicaid Services (CMS), under the Quality Measure Development and Maintenance contract with CMS. These include the Dialysis Facility Compare (DFC) Measures and the development of new quality measures that will be implemented in the future.
ESRD Network Organizations FAQ
An ESRD Network is defined in the Code of Federal Regulations (CFR), at 42 CFR Part 405, Subpart U as all Medicare-approved ESRD facilities in a designated geographic area specified by CMS. These regulations require ESRD treatment facilities to be organized into groups called Networks in order to promote a system of effective coordination.
ESRD Prospective Payment System (PPS) Information
The ESRD PPS provides a patient-level and facility-level adjusted per treatment (dialysis) payment to ESRD facilities for renal dialysis services provided in an ESRD facility or in a beneficiary’s home. The bundled per treatment payment includes drugs, laboratory services, supplies and capital-related costs related to furnishing maintenance dialysis.
ESRD Treatment Choices Model
CMS is proposing the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model to encourage greater use of home dialysis and kidney transplants for Medicare beneficiaries with ESRD, while reducing Medicare expenditures and preserving or enhancing the quality of care furnished to beneficiaries with ESRD.
Voluntary Kidney Models
Kidney Care Choices (KCC) builds upon the existing Comprehensive End Stage Renal Disease (ESRD) Care (CEC) Model structure – in which dialysis facilities, nephrologists, and other health care providers form ESRD-focused accountable care organizations to manage care for beneficiaries with ESRD – by adding strong financial incentives for health care providers to manage the care for Medicare beneficiaries with chronic kidney disease (CKD) stages 4 and 5 and ESRD, to delay the onset of dialysis and to incentivize kidney transplantation.
FDA
The Kidney Health Initiative
A public- private partnership between the US Food and Drug Administration, American Society of Nephrology and the community, catalyzes innovation and the development of safe and effective patient-centered therapies for people living with kidney diseases. Visit the Take Action page to read about the KHI Technology Roadmap for Renal Replacement Therapy and other important projects.
HRSA
Organ Donation and Transplantation Information (not specific to kidneys)
IHS
Chronic Kidney Disease Screening and Monitoring
Special Diabetes Program for Indians (SDPI) grantees are required to implement one of 19 SDPI Diabetes Best Practices. The best practices are focused areas for improvement of diabetes prevention and treatment outcomes in communities and clinics. Chronic Kidney Disease Screening and Monitoring is one of the best practices that grantees can select to implement within their programs.
Diabetes Standards of Care & Clinical Practice Resources
Screening and Monitoring of Chronic Kidney Disease in Diabetes FAQ
Clinical resources intended to provide guidance to clinicians and educators as they care for AI/AN people who have or are at risk for type 2 diabetes.
Diabetes Treatment Algorithms: Chronic Kidney Disease in Type 2 Diabetes
Diabetes Treatment Algorithms were developed to provide clinicians with a quick reference to treatment algorithms based on national guidelines and the Standards of Care and Clinical Practice Recommendations for Type 2 Diabetes.
Kidney Health Resources
Includes kidney health resources for patients, community members, tribal leaders, clinicians and diabetes educators.
Kidney Damage “Nephropathy” (basic booklet)
Chronic Kidney Disease – What Does it Mean for Me?
Free materials and resources available via the online catalog for patients or health care providers.
Native Americans with Diabetes
CDC Vital signs materials on reduced kidney failure in American Indians and Alaska Native people with Diabetes.
What the Diabetes Team Needs to Know about End Stage Renal Disease (ESRD)
Recorded webinar for Diabetes Online CME/CE Education for clinicians and other health professionals serving in the HIS.
NIH
Clinical Trials in Organ Transplantation (CTOT)
The Clinical Trials in Organ Transplantation (CTOT) project is a cooperative research program sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). CTOT is an investigative consortium for conducting clinical and associated mechanistic studies that will lead to improved outcomes for transplant recipients. The purpose of these studies is to improve short and long-term graft and patient survival.
Clinical Trials in Organ Transplantation in Children (CTOT-C)
The Clinical Trials in Organ Transplantation in Children (CTOT-C) project is a cooperative research program sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). CTOT-C is an investigative consortium for conducting multi-institutional clinical and associated mechanistic studies that will lead to improved outcomes for pediatric transplant recipients. The purpose of these studies is to improve short and long-term graft and patient survival in children who have undergone heart, lung or kidney transplantation.
HOPE in Action kidney transplant trial: HIV+ to HIV+ transplantation: HOPE in Action NIH blog
APOL1 Long-term Kidney Transplant Outcomes Network
Assesses kidney allograft survival from donors with recent African ancestry based on donor and recipient APOL1 genes.
Immune Tolerance Network
For people who receive an organ transplant, immunosuppressive drugs are a lifeline that prevents their immune system from rejecting the transplant. However, these drugs work by suppressing all of the immune system - even the parts that protect from real threats. This means that people taking immunosuppressive drugs are at risk of developing serious infections. The Immune Tolerance Network (ITN) is working to find new therapies that reprogram the immune system in a way that will allow people to maintain the health of the organ without long-term use of immunosuppression, also known as tolerance.
National Kidney Disease Education Program
Improving the understanding, detection, and management of kidney disease.
United States Renal Data System
The United States Renal Data System (USRDS) is a national data system that collects, analyzes, and distributes information about chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States. The USRDS is funded directly by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
